Nitric oxide: A key mediator in the early and late phase of carrageenan-induced rat paw inflammation

British Journal of Pharmacology

Volumn 118, Issue 4, 1996, Pages 829-838

  Salvemini, Daniela ^a   Wang, Zhi Qiang ^a   Wyatt, Pamela S ^a   Bourdon, David M ^a   Marino, Margaret H ^a   Manning, Pamela T ^a   Currie, Mark G ^a  

^a PFIZER INC   (United States)

Author keywords

Acute inflammation; Carrageenan; Nitric oxide synthase inhibitors; Peroxynitrite; Superoxide anion

Indexed keywords

AMINOGUANIDINE; CARRAGEENAN; CATALASE; COLCHICINE; COPPER ZINC SUPEROXIDE DISMUTASE; DEFEROXAMINE; LYSINE DERIVATIVE; MESSENGER RNA; N(G) METHYLARGININE; N(G) NITROARGININE METHYL ESTER; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; OXYGEN RADICAL; PROSTAGLANDIN; PROSTAGLANDIN E2; PROTEIN; RECOMBINANT PROTEIN; RIBONUCLEASE; SUPEROXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IMMUNOBLOTTING; INFLAMMATION; MALE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; RAT;

EID: 0029763960     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15475.x     Document Type: Article

References (38)

1. BECKMAN, J.S., BECKMAN, T.W., CHEN, T.W., MARSHALL, P.A. & FREEMAN, B.A. (1990). Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. U.S.A., 87, 1620-1624.
2. BOUGHTON-SMITH, N.K., DEAKIN, A.M., FOLLENFANT, R.L., WHITTLE, B.J.R & GARLAND, L.G. (1993). Role of oxygen radicals and arachidonic acid metabolites in the reverse passive Arthus reaction and carrageenin paw oedema in the rat. Br. J. Pharmacol., 110, 896-902.
3. BRADLEY, P.P., PRIEBAT, D.A., CHRISTENSEN, R.D. & ROTHSTEIN, G. (1982). Measurement of cutaneous inflammation. Estimation of neutrophil content with an enzyme marker. J. Invest. Dermatol., 78, 206-209.
4. CONNOR, J., MANNING, P.T., SETTLE, S.L., MOORE, W.M., JEROME, G.M., WEBBER, R.K., TJOENG, F.S. & CLIRRIE, M.G. (1995). Suppression of adjuvant-induced arthritis by selective inhibition of inducible nitric oxide synthase. Eur. J. Pharmacol., 273, 15-24.
5. CORBETT, J.A., KWON, G., TURK, J. & MCDANIEL, M.L. (1993). IL-1β induces the coexpression of both nitric oxide synthase and cyclooxygenase by islets of langerhans: activation of cyclooxygenase by nitric oxide. Biochemistry, 32, 13767-13770.
6. DAVIDGE, S.T., BAKER, P.N., MCLAUGHLIN, M.K. & ROBERTS, J.M. (1995). Nitric oxide produced by endothelial cells increases production of eicosanoids through activation of prostaglandin H synthase. Circ. Res., 77, 274-283.
7. DI ROSA, M., GIROUD, J.P. & WILLOUGHBY, D.A. (1971). Studies of mediators of the acute inflammatory response induced in rats in different sites by carrageenin and turpentine. J. Pathol., 104, 15-29.
8. DI ROSA, M. & SORRENTINO. L. (1968). The mechanism of the inflammatory effect of carrageenin. Eur. J. Pharmacol., 4, 340-343.
9. DI ROSA, M. & WILLOUGHBY, D.A. (1971). Screens for antiinflammatory drugs. J. Pharm. Pharmacol., 23, 297-300.
10. FANTONE, J.C. & WARD, P.A. (1982). Role of oxygen-derived free radicals and metabolites in leukocyte-dependent inflammatory reactions. Am. J. Pathol., 107, 397-418.
11. GRIFFITHS, M.J.D., MESSENT, M., MACALLISTER, R.J. & EVANS, T.W. (1993). Aminoguanidine selectively inhibits inducible nitric oxide synthase. Br. J. Pharmacol., 110, 963-968.
12. HAJJAR, D.P., LANDER, H.M., PEARCE, F.S., UPMACIS, R.K. & POMERANTZ, K.B. (1995). Nitric oxide enhances prostaglandin-H synthase activity by a heme-independent mechanism: evidence implicating nitrosothiols. J. Am. Chem. Soc., 117, 3340-3346.
13. HIRSCHELMANN, R. & BEKEMEIR, H. (1981). Effects of catalase, peroxidase, superoxide dismutase and 10 scavengers of oxygen radicals in carrageenin edema and in adjuvant arthritis of rats. Experientia, 37, 1313-1314.
14. IALENTI, A., IANARO, A., MONCADA, S. & DI ROSA, M. (1992). Modulation of acute inflammation by endogenous nitric oxide. Eur. J. Pharmacol., 211, 177-182.
15. IANARO, A., O'DONNELL, C.A., DI ROSA, M. & LIEW, F.Y. (1994). A nitric oxide synthase inhibitor reduces inflammation, down-regulates inflammatory cytokines and enhances interleukin-10 production in carrageenin-induced oedema in mice. Immunol., 82, 370-375.
16. 2 production by vascular smooth muscle cells. Biochem. Biophys. Res. Commun., 194, 420-424.
17. LAIGHT, D.W., LAD, N., WOODWARD, B. & WATERFALL, J.F. (1994). Assessment of myeloperoxidase activity in renal tissue after ischaemia/reperfusion. Eur. J. Pharmacol., 292, 81-88.
18. MISKO, T.P., MOORE, W.M., KASTEN, T.P., NICKOLS, G.A., CORBETT, J.A., TILTON, R.G., MCDANIEL, M.L., WILLIAMSON, J.R. & CURRIE, M.G. (1993a). Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur. J. Pharmacol., 233, 119-225.
19. MISKO, T.P., SCHILLING, R.J., SALVEMINI, D., MOORE, W.M. & CURRIE, M.G. (1993b). A fluorometric assay for the measurements of nitrite in biological samples. Anal. Biochem. 214, 11-16.
20. MONCADA, S. & HIGGS, A. (1993). The L-arginine-nitric oxide pathway. N. Engl. J. Med., 329, 2002-2012.
21. MONCADA, S., PALMER, R.M.J. & HIGGS, E.A. (1991). Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev., 43, 109-141.
22. 6-(1-Iminoethyl)lysine: A selective inhibitor of inducible nitric oxide synthase. J. Med. Chem., 37, 3886-3888.
23. RADI, R., BECKMAN, J.S., BUSH, K.M. & FREEMAN, B.A. (1991). Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch. Biochem. Biophys., 288, 481-487.
24. 2 release from the hypothalamus. Proc. Natl. Acad. Sci. U.S.A., 89, 11543-11546.
25. RUBBO, H., RADI, R., TRUJILLO, M., TELLERI, R., KALYANARAMAN, B., BARNES, S., KIRK, M. & FREEMAN, B.A. (1994). Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation. J. Biol. Chem., 269, 26066-26075.
26. SALVEMINI, D., MANNING, P.T., ZWEIFEL, B.S., SEIBERT, K., CONNOR, J., CURRIE, M.G., NEEDLEMAN, P. & MASFERRER, J.L. (1995a). Dual inhibition of nitric oxide and prostaglandin production contributes to the antiinflammatory properties of nitric oxide synthase inhibitors. J. Clin. Invest., 96, 301-308.
27. SALVEMINI, D., MISKO, T.P., SEIBERT, K., MASFERRER, J.L., CURRIE, M.G. & NEEDLEMAN, P. (1993). Nitric oxide activates cyclooxygenase enzymes. Proc. Natl. Acad. Sci. U.S.A., 90, 7240-7244.
28. SALVEMINI, D., SEIBERT, K., MASFERRER, J.H., MISKO, T.P., CURRIE, M.G. & NEEDLEMAN, P. (1994). Endogenous nitric oxide enhances prostaglandin production in a model of renal inflammation. J. Clin. Invest., 93, 1940-1947.
29. SALVEMINI, D., SETTLE, S.L., MASFERRER, J.L., SEIBERT, K., CURRIE, M.G. & NEEDLEMAN, P. (1995b). Regulation of prostaglandin production by nitric oxide; an in vivo analysis. Br. J. Pharmacol., 114, 1171-1178.
30. SAUTEBIN, L. & DI ROSA, M. (1994). Nitric oxide modulates prostacyclin biosynthesis in the lung of endotoxin-treated rats. Eur. J. Pharmacol, 262, 193-196.
31. SAUTEBIN, L., IALENTI, A., IANARO, A. & DI ROSA, M. (1995). Modulation by nitric oxide of prostaglandin biosynthesis in the rat. Br. J. Pharmacol., 114, 323-328.
32. SIEBERT, K., ZHANG, Y., LEAHY, K., HAUSER, S., MASFERRER, J., PERKINS, W., LEE, L. & ISAKSON, P. (1994). Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc. Natl. Acad. Sci. U.S.A., 91, 12013-12017.
33. SCHRAUFSTATTER, I.U., HYSLOP, P.A., JACKSON, J. & COCHRANE, C.C. (1987). Oxidant injury of cells. Int. J. Tissue React., 9, 317-324.
34. VINEGAR, R., SCHREIBER, W. & HUGO, R. (1969). Biphasic development of carrageenan edema in rats. J. Pharmacol. Exp. Ther., 166, 96-103.
35. VINEGAR, R., MACKLIN, A.W., TRUAX, J.F. & SELPH, J.L. (1971). Histopathological and pharmacological study of carrageenin inflammation in the rat. Pharmacologist., 13, 284-290.
36. WARREN, J.B., COUGHLAN, M.L. & WILLIAMS, T.J. (1992). Endotoxin-induced vasodilation in anaesthetized rat skin involves nitric oxide and prostaglandin synthesis. Br. J. Pharmacol., 106, 953-957.
37. 2 in neutrophil recruitment into sites of dermal and pulmonary vasculitis. Free Rad. Biol. Med., 8, 163-172.
38. WU, C.C., CHEN, S.J., SZABO, C., THIEMERMANN, C. & VANE, J.R. (1995). Aminoguanidine attenuates the delayed circulatory failure and improves survival in rodent models of endotoxic shock. Br. J. Pharmacol., 114, 1666-1672.